Harnessing Tissue Specific Activation of Inducible Cytokines for Treatment of Oncology and Autoimmunity
Time: 10:00 am
day: Conference Day Two
Details:
Outlining Werewolf Therapeutics PREDATOR™ technology
Exploring how technology takes advantage of protease selective linkers
Rendering biologically potent cytokines inactive in the periphery but allow activation in the disease target tissue of interest
